[
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=d80c6dd44ee9cca73c121d145ef6b068a184199b28c72c0cf31c39ccc0508b67",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739896620,
      "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "id": 132788023,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=d80c6dd44ee9cca73c121d145ef6b068a184199b28c72c0cf31c39ccc0508b67"
    }
  },
  {
    "ts": null,
    "headline": "Nurix Therapeutics: A Story To Monitor",
    "summary": "Nurix Therapeutics, Inc. stock slid 40% after promising NX-5948 results in CLL. NX-5948 shows efficacy in heavily pre-treated CLL patients, click for more on NRIX.",
    "url": "https://finnhub.io/api/news?id=60388fed80d28cbd7b31c5f3a4d32f3030b942e762d20c7a6eb37dfea4cff31a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739884338,
      "headline": "Nurix Therapeutics: A Story To Monitor",
      "id": 132779003,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1281832252/image_1281832252.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Nurix Therapeutics, Inc. stock slid 40% after promising NX-5948 results in CLL. NX-5948 shows efficacy in heavily pre-treated CLL patients, click for more on NRIX.",
      "url": "https://finnhub.io/api/news?id=60388fed80d28cbd7b31c5f3a4d32f3030b942e762d20c7a6eb37dfea4cff31a"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Gets FDA Priority Review of Twice-Yearly Shot to Prevent HIV",
    "summary": "Gilead Gets FDA Priority Review of Twice-Yearly Shot to Prevent HIV",
    "url": "https://finnhub.io/api/news?id=4ba1ed12a9c346f50e99c03f5e242f916a8a388aae29d2abcd162f85f3cfd766",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739872020,
      "headline": "Gilead Gets FDA Priority Review of Twice-Yearly Shot to Prevent HIV",
      "id": 132770781,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Gets FDA Priority Review of Twice-Yearly Shot to Prevent HIV",
      "url": "https://finnhub.io/api/news?id=4ba1ed12a9c346f50e99c03f5e242f916a8a388aae29d2abcd162f85f3cfd766"
    }
  }
]